07:28 AM EDT, 08/20/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) said Tuesday that the US Food and Drug Administration had completed its review of all major and minor technical sections for Credelio Quattro, with the final 60-day administrative review currently underway.

Elanco said the broad spectrum parasiticide product is on track for approval in October and will be launched in Q1.

Elanco said it is seeking approval for Credelio Quattro "for indications that would give the broadest parasite coverage including fleas, ticks, heartworms and other internal parasites, like tapeworm."

Price: 15.01, Change: +0.19, Percent Change: +1.28